Roughly 10% to 15% people with mild cognitive impairment are later diagnosed with dementia.
Primary care physicians know the importance of early diagnosis, yet many feel unprepared to properly diagnose and care for patients suffering from dementia.
It's not rocket science, but it is brain science. Neurotrack invests in and leverages the latest neuroscience research to deliver convenient, digital solutions to help doctors and health care providers screen faster, intervene earlier, and create better outcomes for patients.
A comprehensive list of published studies and articles about and/or utilizing our products.
Health coaching and education can both improve cognition, but coaching may be more effective and may yield increased protection against ADRD risk.
JMIR Research Protocols
The intervention in the Digital, Cognitive, Multi-domain Alzheimer Risk Velocity is uniquely designed to reduce the risk of AD through a web-based health coaching experience that addresses the modifiable lifestyle-based risk factors.
JMIR Formative Research
There is an urgent, growing need for remote cognitive assessment for individuals with cognitive impairment. The Neurotrack Cognitive Battery (NCB) is a brief, easy-to-administer, and reliable assessment for remote cognitive testing.
Frontiers in Psychiatry
This study provides preliminary estimates of classification accuracy of the digital technologies and describes digital biomarkers that could be useful for characterizing unipolar depression.
Invited editorial about the diagnosis, treatment, and prevention of cognitive decline via digital intervention.
Supplementation with inositol-stabilized arginine silicate (ASI) helped young adults improve performance on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).
The Journal of Prevention of Alzheimer's Disease
This retrospective study analyzed the frequency of and factors associated with environmental distractions during a brief digital assessment taken at home. A total of 7.4% of test administrations included distractions.
Significant correlations existed between measures of memory and physical function suggesting a positive relationship between physical function and cognitive status.
Current Alzheimer Research
In this review, we summarize some of the biological mechanisms of key compounds in their relation to AD and how they fit into a dietary pattern that supports the role of diet as a risk reducing factor for AD.
A five-minute, digital version of the visual paired comparison task successfully predicts cognitive outcomes. This is a less burdensome and more scalable assessment, enabling longitudinal monitoring of cognitive status in resource-limited environments.
The review presented here by Neurotrack’s scientific team covers completed and upcoming studies that use multi-domain lifestyle interventions to promote cognitive health and decrease the risk of Alzheimer’s Disease and related dementias. These include the upcoming World-Wide FINGERS studies and a number of studies supported by digital intervention strategies.
JMIR MHealth and UHealth
This paper details the cross-cultural feasibility of the Neurotrack platform in a Japanese population. Similar to previous literature, platform engagement metrics were highly correlated, with greater engagement shown to relate to increased participation in healthy lifestyle behaviors.
There is an abundant amount of proteins and amino acids in our regular diet, and regular consumption is linked to a number of disease-related risk factors for Alzheimer’s Disease and related dementias. This review by Neurotrack’s scientific team covers the preventative roles regular proteins and amino acids play, as well as makes recommendations on proper intake to decrease risk of cognitive decline.
Journal of Alzheimer’s Disease
Exercise is known to be beneficial to the brain and cardiovascular system. This review paper summarizes what is currently known about the relationship between exercise and Alzheimer’s disease.
This paper demonstrates the stability and reliability of Neurotrack’s 5-minute eye tracking test. The test also correlates moderately with gold standard cognitive composites and Neurotrack’s 30-minute eye tracking test.
Telemedicine and e-Health
This paper validates the use of Neurotrack’s proprietary algorithm for scoring eye tracking data. Study participants completed the Neurotrack 5-minute eye tracking test on 3 separate occasions while being simultaneously recorded by a webcam and a research-grade eye tracking camera. The data was equivalent across camera types and scoring modalities.
This paper details the results of the VC Health study, a pilot study on the Cognitive Health Program. Over 80 older adults with subjective memory decline enrolled in the study and were given access to the Cognitive Health Program. After one year, participants experienced significant improvements in cognitive function, anxiety, and depression.
JMIR Research Protocols
This paper details the protocol and baseline characteristics of the participants in the VC Health study, a pilot study on the Cognitive Health Program. A total of 82 adults age 60-75 with subjective memory complaints enrolled in the year-long study and used the program.
Journal of Medical Internet Research
This study demonstrated modest correlations between Neurotrack’s 30-minute eye tracking test and gold-standard cognitive assessments known to be sensitive to early signs of decline. The data supports the use of eye tracking tests that utilize device-embedded cameras to provide efficient and scalable evaluation of cognitive performance.
Frontiers in Neuroscience
This study validated the use of standard webcams in place of expensive research-grade eye tracking cameras for one of Neurotrack’s eye tracking tests. This data supports the scalability of Neurotrack’s tests, as no special equipment is required except a laptop, tablet, or smartphone with a webcam.